DTaP-IPV vaccine

DTaP-IPV vaccine
Combination of
DTaP vaccine Vaccine
Inactivated poliovirus vaccine Vaccine
Clinical data
Trade names Kinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others
AHFS/Drugs.com Kinrix Quadracel
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    administration    		 Intramuscular injection
    ATC code

    DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine.[1] It is also known as DTaP/IPV or dTaP/IPV or DTPa-IPV. It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.

    Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[2] and Quadracel from Sanofi Pasteur.[3]

    References

    1. ↑ "Diphtheria, Tetanus, Pertussis (Acellular, Component) And Poliomyelitis (Inactivated) Vaccine (Adsorbed)". Drugs.com. Retrieved 15 July 2018.
    2. ↑ "Kinrix". US Food and Drug Administration. Retrieved 15 July 2018.
    3. ↑ "Quadracel". US Food and Drug Administration. Retrieved 15 July 2018.
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.